David Turkaly
Stock Analyst at Citizens JMP
(0.27)
# 4,264
Out of 4,476 analysts
456
Total ratings
39.6%
Success rate
-3.8%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintained: Buy | $85 → $115 | $109.89 | +4.65% | 21 | May 8, 2026 | |
| MDXG MiMedx Group | Maintained: Buy | $7 → $6 | $3.95 | +51.90% | 3 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Buy | $125 → $105 | $87.47 | +20.04% | 29 | Apr 29, 2026 | |
| AXGN Axogen | Maintained: Buy | $42 → $50 | $45.89 | +8.96% | 30 | Apr 29, 2026 | |
| TELA TELA Bio | Maintained: Buy | $5 → $3 | $0.7214 | +315.86% | 23 | Mar 27, 2026 | |
| SYK Stryker | Upgraded: Buy | $440 | $326.54 | +34.75% | 21 | Dec 19, 2025 | |
| APYX Apyx Medical | Upgraded: Buy | $8 | $4.30 | +86.05% | 34 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintained: Buy | $35 → $25 | $19.95 | +25.31% | 37 | Oct 10, 2025 | |
| GMED Globus Medical | Reiterated: Hold | n/a | $80.12 | - | 24 | Aug 20, 2025 | |
| IART Integra LifeSciences Holdings | Reiterated: Buy | $25 | $18.05 | +38.50% | 31 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.41 | +396.45% | 23 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $75.07 | n/a | 33 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $280 | $218.20 | n/a | 40 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.93 | n/a | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $55 | $22.50 | n/a | 4 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $17.11 | n/a | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $133.99 | n/a | 24 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.94 | n/a | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.77 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $77.49 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.14 | n/a | 2 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $10.81 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.35 | n/a | 1 | Jun 25, 2009 |
Lantheus Holdings
May 8, 2026
Maintained: Buy
Price Target: $85 → $115
Current: $109.89
Upside: +4.65%
MiMedx Group
Apr 30, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $3.95
Upside: +51.90%
Zimmer Biomet Holdings
Apr 29, 2026
Maintained: Buy
Price Target: $125 → $105
Current: $87.47
Upside: +20.04%
Axogen
Apr 29, 2026
Maintained: Buy
Price Target: $42 → $50
Current: $45.89
Upside: +8.96%
TELA Bio
Mar 27, 2026
Maintained: Buy
Price Target: $5 → $3
Current: $0.7214
Upside: +315.86%
Stryker
Dec 19, 2025
Upgraded: Buy
Price Target: $440
Current: $326.54
Upside: +34.75%
Apyx Medical
Nov 12, 2025
Upgraded: Buy
Price Target: $8
Current: $4.30
Upside: +86.05%
OrthoPediatrics
Oct 10, 2025
Maintained: Buy
Price Target: $35 → $25
Current: $19.95
Upside: +25.31%
Globus Medical
Aug 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $80.12
Upside: -
Integra LifeSciences Holdings
Aug 1, 2025
Reiterated: Buy
Price Target: $25
Current: $18.05
Upside: +38.50%
Jul 28, 2025
Reiterated: Buy
Price Target: $7
Current: $1.41
Upside: +396.45%
May 20, 2025
Reiterated: Buy
Price Target: $100
Current: $75.07
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $265 → $280
Current: $218.20
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $24.93
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $62 → $55
Current: $22.50
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $32
Current: $17.11
Upside: n/a
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $133.99
Upside: n/a
Mar 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.94
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $8.77
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $77.49
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $9.14
Upside: n/a
Jun 3, 2016
Reiterated: Buy
Price Target: $17
Current: $10.81
Upside: n/a
Jun 25, 2009
Downgraded: Hold
Price Target: n/a
Current: $4.35
Upside: n/a